Polymerase chain reaction-restriction fragment length polymorphism analysis of Helicobacter pylori isolates from patients with gastrointestinal complaints in Eastern Turkey

dc.contributor.authorOzbey, Gokben
dc.contributor.authorBahcecioglu, Ibrahim Halil
dc.contributor.authorCeribasi, Songul
dc.contributor.authorMuz, Adile
dc.date.accessioned2026-08-12T17:01:27Z
dc.date.issued2012
dc.departmentFırat Üniversitesi
dc.description.abstractThe aim of this study was to investigate the genetic variations among isolates of Helicobacter pylori (H. pylori) obtained from patients with gastritis (G) and peptic ulcer (PU) in Elazig Province, East of Turkey and to determine association between restriction fragment length polymorphism (RFLP) types and clinical/histopathological outcomes. Determining the dominant genotypes among H. pylori isolates would detect potential risk and aid in the development of improved treatment and control strategies. Sixty one H. pylori-isolates [29 males and 32 females, 51 with G, 10 with PU (duodenal ulcer (DU) or gastric ulcer (GU)] were examined by polymerase chain reaction-restriction fragment length polymorphism analysis (PCR-RFLP) for detecting the genetic diversity among H. pylori isolates. By (PCR-RFLP) analysis, H. pylori isolates yielded five (A-E) different band profiles. The most common type of H. pylori isolates from patients with chronic active, chronic active non-atrophic and chronic atrophic G was type B (55, 88.9 and 100%, respectively). However, most of the isolates from patients with DU and GU were type D (75 and 100%, respectively). To the best of our knowledge, this is the first report on PCR-RFLP analysis of H. pylori isolates in Elazig Province, the East of Turkey. This study indicated that the genetic heterogenecity among H. pylori isolated from patients is low, and the clinical/histopathological outcomes of H. pylori isolates associated to the RFLP types.
dc.description.sponsorshipFirat University Scientific Research Projects Unit [FUBAP 1609]
dc.description.sponsorshipThis work was part of the project supported by the Firat University Scientific Research Projects Unit (FUBAP 1609). We thanks to Unal KILINC, Director of the Elazig Veterinary Control and Research Institute for his invaluable support during our study, Dr. Vildan CANER, Department of Medical Biology, School of Medicine, Pamukkale University, Denizli, Turkey for supplying some clinical strains of H. Pylori, and Dr. Gireesh RAJASHEKARA, Food Animal Health Research Program, the Ohio State University, Ohio, USA and Dr. Guillermo I. Perez Perez, NYU School of Medicine, Department of Medicine and Microbiology, New York, USA for helpful comments on the manuscript.
dc.identifier.doi10.5897/AJMR12.645
dc.identifier.endpage4072
dc.identifier.issn1996-0808
dc.identifier.issue18
dc.identifier.startpage4068
dc.identifier.urihttps://doi.org/10.5897/AJMR12.645
dc.identifier.urihttps://hdl.handle.net/11508/47716
dc.identifier.volume6
dc.identifier.wosWOS:000307404400018
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherAcademic Journals
dc.relation.ispartofAfrican Journal of Microbiology Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectHelicobacter pylori
dc.subjectpatients
dc.subjectgenetic variation
dc.subjectpolymerase chain reaction-restriction fragment length polymorphism
dc.titlePolymerase chain reaction-restriction fragment length polymorphism analysis of Helicobacter pylori isolates from patients with gastrointestinal complaints in Eastern Turkey
dc.typeArticle

Dosyalar